Clinical Trial Update: A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating mitoguazone dihydrochloride in AIDS-related non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Lymphoma Non-hodgkin

Drugs mentioned

• Mitoguazone dihydrochloride (mitoguazone dihydrochloride)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Lymphoma, Non-Hodgkin, HIV Infections | Phase 2 | Status: COMPLETED